A novel TLR9 agonist as experimental therapy for prostate cancer

被引:0
|
作者
Rayburn, E. R. [1 ]
Wang, H. [1 ]
Zhang, R. [1 ]
机构
[1] Univ Alabama, Dept Pharmacol & Toxicol, Div Clin Pharmacol, Birmingham, AL USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:211 / 212
页数:2
相关论文
共 50 条
  • [21] Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy
    Jin, Yizhen
    Zhuang, Yuxin
    Dong, Xiaowu
    Liu, Mei
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (08) : 841 - 851
  • [22] Coexpression of TLR9 and VEGF-C is associated with lymphatic metastasis in prostate cancer
    Zeng, Xian-Zi
    Huang, Zhan-Sen
    Fang, Hong-Peng
    Wu, Jie-Ying
    Huang, Qun-Xiong
    Zhuang, Chu-Bin
    Zhou, Jing
    Di, Jin-Ming
    ASIAN JOURNAL OF ANDROLOGY, 2022, 24 (04) : 380 - 385
  • [23] Hemozoin: Malaria's "Built-In" Adjuvant and TLR9 Agonist
    Wagner, Hermann
    CELL HOST & MICROBE, 2010, 7 (01) : 5 - 6
  • [24] Local treatment with novel TLR9 agonist IMO-2125 demonstrates antitumor activity in preclinical models of pancreatic cancer
    Wang, Daqing
    Argon, Evren Kocabas
    Zhu, Fugang
    Agarwal, Sudhir
    CANCER RESEARCH, 2017, 77
  • [25] A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine
    Conforti, Antonella
    Cipriani, Barbara
    Peruzzi, Daniela
    Dharmapuri, Sridhar
    Kandimalla, Ekambar R.
    Agrawal, Sudhir
    Mori, Federica
    Ciliberto, Gennaro
    La Monica, Nicola
    Aurisicchio, Luigi
    VACCINE, 2010, 28 (20) : 3522 - 3530
  • [26] Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
    Cascini, Caterina
    Ratti, Chiara
    Botti, Laura
    Parma, Beatrice
    Cancila, Valeria
    Salvaggio, Adriana
    Meazza, Cristina
    Tripodo, Claudio
    Colombo, Mario P.
    Chiodoni, Claudia
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [27] Homeostatic effects of TLR9 signaling in experimental colitis
    Lee, Jongdae
    Rachmilewitz, Daniel
    Raz, Eyal
    INFLAMMATORY BOWEL DISEASE: GENETICS, BARRIER FUNCTION, IMMUNOLOGIC MECHANISMS, AND MICROBIAL PATHWAYS, 2006, 1072 : 351 - 355
  • [28] BACTERIAL DNA, A TLR9 AGONIST, IMPAIRS INNATE IMMUNE FUNCTION
    Murphey, E. D.
    Sherwood, E. R.
    SHOCK, 2011, 35 : 35 - 36
  • [29] Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
    Caterina Cascini
    Chiara Ratti
    Laura Botti
    Beatrice Parma
    Valeria Cancila
    Adriana Salvaggio
    Cristina Meazza
    Claudio Tripodo
    Mario P. Colombo
    Claudia Chiodoni
    Journal of Experimental & Clinical Cancer Research, 42
  • [30] Turning on TLR9
    Sharon Ahmad
    Nature Reviews Immunology, 2007, 7 : 496 - 496